17 days ago
AMLX
AnalystsSeamus FernandezSeamus Fernandez's Stock Forecasts
AnalystsSeamus Fernandez
Analyst Ranking
Top 2%
#68 out of 5510 analysts
Average Return
+59.57%
Win Rate
67%74 out of 111
Risk vs Reward
Poor
Good
Seamus Fernandez's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +768.16% | $25.50 | $221.38 | 2025-05-16 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +673.26% | $13.50 | $104.39 | 2024-11-08 - 2025-11-07 | Strong Buy |
Mbx Biosciences IncMBX | +424.08% | $6.27 | $32.86 | 2025-04-10 - 2026-04-09 | Strong Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Strong Buy |
Seamus Fernandez Analyst Color
Get additional color on Seamus Fernandez's coverage of popular stocks
25 days ago
AMLX
a month ago
SEPN
a month ago
ARQT
a month ago
BMY
3 months ago
AMLX
3 months ago
TENX
5 months ago
LLY
5 months ago
LLY
6 months ago
APGE
6 months ago
AMLX
6 months ago
TENX
7 months ago
RYTM
8 months ago
LLY
8 months ago
GPCR
8 months ago
MBX
9 months ago
TENX
9 months ago
RYTM
9 months ago
BMY
a year ago
LLY
a year ago
CDTX
a year ago
MBX
a year ago
AMLX
a year ago
CDTX
a year ago
CDTX
Seamus Fernandez's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tenax Therapeutics IncTENX | 7 | Hold | N/A | N/A | Downgrades | 13 days ago |
Amylyx Pharmaceuticals IncAMLX | 6 | Strong Buy | $57.00 | +80.27% | Maintains | 17 days ago |
Septerna IncSEPN | 2 | Strong Buy | $51.00 | +32.43% | Maintains | a month ago |
Arcutis Biotherapeutics IncARQT | 5 | Strong Buy | $38.00 | +59.10% | Maintains | a month ago |
Bristol Myers Squibb CoBMY | 9 | Strong Buy | $75.00 | +17.85% | Maintains | a month ago |
Apogee Therapeutics IncAPGE | 10 | Hold | N/A | N/A | Downgrades | 3 months ago |
Avalyn Pharma IncAVLN | 1 | Strong Buy | $80.00 | +138.31% | Initiates Coverage On | 4 months ago |
Eli Lilly & CoLLY | 18 | Strong Buy | $1,183.00 | +6.03% | Reiterates | 4 months ago |
Aclaris Therapeutics IncACRS | 2 | Strong Buy | $12.00 | +125.56% | Initiates Coverage On | 4 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $25.00 | +129.78% | Maintains | 4 months ago |
Generate Biomedicines IncGENB | 1 | Strong Buy | $30.00 | +90.84% | Initiates Coverage On | 6 months ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Strong Buy | $143.00 | +36.57% | Maintains | 7 months ago |
Vaxcyte IncPCVX | 5 | Strong Buy | $116.00 | +95.06% | Reiterates | 7 months ago |
Structure Therapeutics IncGPCR | 3 | Strong Buy | $140.00 | +262.13% | Maintains | 8 months ago |
Mbx Biosciences IncMBX | 5 | Strong Buy | $88.00 | +49.10% | Maintains | 8 months ago |
SanofiSNY | 1 | Hold | N/A | N/A | Downgrades | 9 months ago |
Inventiva SaIVA | 1 | Strong Buy | $11.00 | +173.63% | Maintains | 10 months ago |
Cidara Therapeutics IncCDTX | 6 | Hold | N/A | N/A | Downgrades | 10 months ago |
Arcturus Therapeutics Holdings IncARCT | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Verve Therapeutics IncVERV | 2 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Metsera IncMTSR | 1 | Strong Buy | $56.00 | N/A | Initiates Coverage On | 2 years ago |
Mineralys Therapeutics IncMLYS | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Merck & Co IncMRK | 9 | Strong Buy | $122.00 | N/A | Maintains | 2 years ago |
Gsk PLCGSK | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Hillevax IncHLVX | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Altimmune IncALT | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Icosavax IncICVX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Albireo Pharma IncALBO | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Dice Therapeutics IncDICE2 | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 4 years ago |
Novo Nordisk A SNVO | 2 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Invivyd IncIVVD | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Novartis AgNVS | 3 | Hold | N/A | N/A | Downgrades | 7 years ago |
Dermira IncDERM2 | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Tesaro IncTSRO | 4 | Hold | $75.00 | N/A | Downgrades | 8 years ago |
Intra Cellular Therapies IncITCI | 3 | Buy | $27.00 | N/A | Initiates Coverage On | 8 years ago |
Allergan PLCAGN | 3 | Buy | $220.00 | N/A | Initiates Coverage On | 8 years ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $45.00 | N/A | Maintains | 9 years ago |
Astrazeneca PLCAZN | 3 | Hold | $38.00 | N/A | Maintains | 9 years ago |
Pfizer IncPFE | 1 | Hold | $38.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.